These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63 related articles for article (PubMed ID: 1580782)
1. Pressure sore anemia: response to erythropoietin. Turba RM; Lewis VL; Green D Arch Phys Med Rehabil; 1992 May; 73(5):498-500. PubMed ID: 1580782 [TBL] [Abstract][Full Text] [Related]
2. Recombinant human erythropoietin in the treatment of cancer and chemotherapy-induced anemia: results of double-blind and open-label follow-up studies. Henry DH; Abels RI Semin Oncol; 1994 Apr; 21(2 Suppl 3):21-8. PubMed ID: 8202722 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial. Silver M; Corwin MJ; Bazan A; Gettinger A; Enny C; Corwin HL Crit Care Med; 2006 Sep; 34(9):2310-6. PubMed ID: 16878035 [TBL] [Abstract][Full Text] [Related]
4. [Recombinant erythropoietin in autologous blood donation]. von Bormann B; Weidler B; Friedrich M; von Andrian-Werburg H Anaesthesist; 1991 Jul; 40(7):386-90. PubMed ID: 1928712 [TBL] [Abstract][Full Text] [Related]
5. Successful treatment of refractory anemia with a combination regimen containing recombinant human erythropoietin, low-dose methylprednisolone and nandrolone. Tsiara SN; Chaidos A; Gouva M; Christou L; Panteli K; Kapsali E; Bourantas KL J Exp Clin Cancer Res; 2004 Mar; 23(1):47-52. PubMed ID: 15149150 [TBL] [Abstract][Full Text] [Related]
6. [Human recombinant erythropoietin (rH-EPO) in chronic hemodialysis patients]. Jalil R; Vaccarezza A; Jara A; Lira P; Vial S; Serrano V Rev Med Chil; 1990 Jun; 118(6):629-34. PubMed ID: 1775783 [TBL] [Abstract][Full Text] [Related]
7. Recombinant human erythropoietin treatment: investigational new drug protocol for the anemia of the acquired immunodeficiency syndrome. Overall results. Phair JP; Abels RI; McNeill MV; Sullivan DJ Arch Intern Med; 1993 Dec; 153(23):2669-75. PubMed ID: 8250662 [TBL] [Abstract][Full Text] [Related]
8. Serum erythropoietin and creatinine concentrations as predictive factors for response to recombinant human erythropoietin treatment in anaemic tumour patients on chemotherapy. Fjornes T; Wiedemann GJ; Sack K; Jelkmann W Oncol Rep; 1998; 5(1):81-6. PubMed ID: 9458299 [TBL] [Abstract][Full Text] [Related]
9. Correction of anemia in patients on continuous ambulatory peritoneal dialysis with subcutaneous recombinant erythropoietin twice a week: a long-term study. Cheng IK; Cy C; Chan MK; Yu L; Fang GX; Wei D Clin Nephrol; 1991 May; 35(5):207-12. PubMed ID: 1855328 [TBL] [Abstract][Full Text] [Related]
10. Improvement of anemia by recombinant erythropoietin in patients with myelodysplastic syndromes and aplastic anemia. Bessho M; Jinnai I; Matsuda A; Saito M; Hirashima K Int J Cell Cloning; 1990 Nov; 8(6):445-58. PubMed ID: 2273298 [TBL] [Abstract][Full Text] [Related]
11. Subcutaneous recombinant human erythropoietin in patients on CAPD. Lye WC; Lee EJ Adv Perit Dial; 1991; 7():285-7. PubMed ID: 1680447 [TBL] [Abstract][Full Text] [Related]
12. Current use of recombinant human erythropoietin (r-huEPO) in the management of symptomatic anaemia in patients with myelodysplastic syndromes (MDS). Marques da Costa R Sangre (Barc); 1994 Apr; 39(2):105-10. PubMed ID: 8059287 [TBL] [Abstract][Full Text] [Related]
13. [Treatment of anemia in hemodialysis patients using recombinant human erythropoietin: advantages and disadvantages]. Zehnder C; Blumberg A Schweiz Med Wochenschr; 1989 Mar; 119(9):269-75. PubMed ID: 2711161 [TBL] [Abstract][Full Text] [Related]
14. [Treatment of anemia in patients with chronic renal insufficiency undergoing hemodialysis with recombinant human erythropoietin: 12 months' experience]. de Sousa FT; Prata MM; Barbas JV; dos Santos JP Acta Med Port; 1990; 3(6):347-52. PubMed ID: 2089856 [TBL] [Abstract][Full Text] [Related]
16. Erythropoietin plus granulocyte colony-stimulating factor in the treatment of myelodysplastic syndromes. Identification of a subgroup of responders. The Spanish Erythropathology Group. Remacha AF; Arrizabalaga B; Villegas A; Manteiga R; Calvo T; Julià A; Fernández Fuertes I; González FA; Font L; Juncà J; del Arco A; Malcorra JJ; Equiza EP; de Mendiguren BP; Romero M Haematologica; 1999 Dec; 84(12):1058-64. PubMed ID: 10586205 [TBL] [Abstract][Full Text] [Related]
17. [Successful treatment of anemia in hemolysis patients using recombinant human erythropoietin. Maintenance dosage and serum concentration]. Stutz B; Rhyner K; Vögtli J; Binswanger U Schweiz Med Wochenschr; 1987 Sep; 117(38):1397-402. PubMed ID: 3672079 [TBL] [Abstract][Full Text] [Related]
18. [Effects of rHuEPO on aplastic anemia: results of a phase II clinical study]. Urabe A; Mizoguchi H; Takaku F; Miyazaki T; Yachi A; Niitsu Y; Miura Y; Mutoh Y; Fujioka S; Nomura T Rinsho Ketsueki; 1993 Sep; 34(9):1002-10. PubMed ID: 8230742 [TBL] [Abstract][Full Text] [Related]
19. Once weekly versus twice weekly subcutaneous administration of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis. Lui SF; Law CB; Ting SM; Li P; Lai KN Clin Nephrol; 1991 Nov; 36(5):246-51. PubMed ID: 1752075 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of the effectiveness of treatment with erythropoietin on anemia, cognitive functioning and functions studied by comprehensive geriatric assessment in elderly cancer patients with anemia related to cancer chemotherapy. Massa E; Madeddu C; Lusso MR; Gramignano G; Mantovani G Crit Rev Oncol Hematol; 2006 Feb; 57(2):175-82. PubMed ID: 16213740 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]